Cancer-linked substitutions at R132 of IDH1 (to H, C, S, L, G and V) involve shorter and less basic residues than arginine, consistent with weakened binding of isocitrate (and maybe CO2/bicarbonate) compared to wt IDH1, whilst still enabling 2OG binding7. The gene discussed is IDH1; the disease is cancer.